Drug Discovery AI vs Insitro
Drug Discovery AI vs Insitro, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Drug Discovery AI is on 17/100 and Insitro on 62/100.
Where each one leads
Drug Discovery AI
Leads on none of the measures we hold for both companies.
Insitro
- our overall score: 62/100 against 17/100
- agent readiness: 40/100 against 21/100
- domain rating: 64/100 against 52/100
- headcount: 255 against 35
- LinkedIn following: 42,173 against 13,069
At a glance
| Measure | Drug Discovery AI | Insitro |
|---|---|---|
| What it is | AI platform accelerating the discovery of novel therapeutics. | Data-driven drug discovery and development company using machine learning and high-throughput biology. |
| Category | AI Drug Discovery, Biotech, HealthTech, Drug Discovery | Healthcare, Drug Discovery, Drug Development, DNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2023 | 2018 |
| Headquarters | Boston, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Drug Discovery AI | Insitro |
|---|---|---|
| Employees | 35 | 255 |
| Headcount growthLast 12 months | Not published | +10.9% |
| Total funding | Not published | $243M |
| Latest round | Not published | Series B |
| Valuation | Not published | $7.0B |
| LinkedIn followers | 13,069 | 42,173 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Drug Discovery AI | Insitro |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 17/100 | 62/100 |
| Traction | 16/100 | 60/100 |
| Team | Not published | 50/100 |
| Community | Not published | 8/100 |
| Search visibility | 22/100 | 62/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 64/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Drug Discovery AI | Insitro |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Not detected |
Drug Discovery AI vs Insitro: common questions
Which is better, Drug Discovery AI or Insitro?
On our 0-100 score Insitro rates higher (62/100 against 17/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Drug Discovery AI and Insitro compare on the numbers?
Insitro leads on our overall score (62/100 against 17/100), agent readiness (40/100 against 21/100), domain rating (64/100 against 52/100), headcount (255 against 35), LinkedIn following (42,173 against 13,069).
Read the full Drug Discovery AI review and pricing or the Insitro review and pricing. You can also browse other Drug Discovery AI alternatives we track.